Instil Bio TIL
NASDAQ TIL
$5.78 -0.16 (-2.61%)
As of: Oct 21, 2026 · 3:59 PM EDT

Instil Bio (TIL) Construction in Progress (2020 - 2022)

Updated

Instil Bio's Construction in Progress came in at $104 million for Q4 2022, up 55.2% from $67 million a year earlier.

Analysis

Instil Bio (TIL) Construction in Progress (2020 - 2022) Analysis & Trends

Going back to Q4 2020, Instil Bio's Construction in Progress data covers 5 quarters.

  • Going back by year, Construction in Progress was $67 million in FY2021 (+963.5%) and $6.3 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Instil Bio 38.86 Mn 15.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 104.00 Mn
Dec 31, 2021 67.00 Mn
Sep 30, 2021 44.20 Mn
Jun 30, 2021 22.60 Mn
Dec 31, 2020 6.30 Mn
API Access

Instil Bio Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=TIL&period=max&api_key=YOUR_API_KEY